MetaCap

Accuray (ARAY) vs WORK Medical Technology Group LTD (WOK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Accuray is the larger company by market cap ($6.2 million vs $4.9 million), about 1.3 times the size. WORK Medical Technology Group LTD converts more of its revenue into profit, with a net margin of -10.9% versus -12.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ARAY+718.86%WOK-29.31%
+1481%+675%-130%
Oct 7, 20261 yearNov 20, 2026
ARAY+803.35%WOK-28.39%
+1178%+533%-111%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ARAY versus WOK key metrics
MetricARAYWOK
Share price$2.08$1.10
Market cap$6.22M$4.90M
1-day change-2.12%-5.13%
YTD return+153.05%—
1-year return+97.62%—
5-year return-59.47%—
EPS (TTM)$-5.60$-51,993.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$401.95M$9.85M
Revenue growth (YoY)-12.34%-14.41%
Net income (latest FY)$-49.19M$-1.07M
Gross margin27.73%23.81%
Operating margin-6.58%—
Net margin-12.24%-10.89%
52-week high$45.20$83,600.00
52-week low$2.05$0.91
Distance from 52-week high-95.41%-100.00%
Analyst consensusnone—
Average volume201.35K71.02K
Shares outstanding3.00M4.42M
Employees809238
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Accuray

ARAY stock →

Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.

Health Care · Medical/Dental Instruments · 809 employees

About WORK Medical Technology Group LTD

WOK stock →

WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators.

Health Care · Medical/Dental Instruments · 238 employees

ARAY vs WOK FAQ

Which is bigger, Accuray or WORK Medical Technology Group LTD?

Accuray (ARAY) is larger, with a market capitalization of $6.22M compared with $4.90M for WORK Medical Technology Group LTD (WOK).

Are Accuray and WORK Medical Technology Group LTD in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons